HELP
Cybin Inc. Common Stock NASDAQ Listed Sep 13, 2019$4.67
+1.97%
vs $4.58
Mkt Cap $94.4M
52w Low $3.87
16.5% of range
52w High $8.71
50d MA $4.87
200d MA $5.91
P/E (TTM)
-7.7x
EV/EBITDA
—
P/B
0.4x
Debt/Equity
0.0x
ROE
—
P/FCF
-0.9x
RSI (14)
52.80
ATR (14)
$0.30
Beta
1.04
50d MA
$4.87
200d MA
$5.91
Avg Volume
629.0K
Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder
100 King Street West · Toronto, ON M5X 1C9 · CA
Data updated apr 25, 2026 1:18pm
· Source: financialmodelingprep.com